DiaPro-MS (Q3989004)

From EU Knowledge Graph
Revision as of 17:05, 12 January 2022 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in es, and other parts: Adding Spanish translations)
Jump to navigation Jump to search
Project Q3989004 in Netherlands
Language Label Description Also known as
English
DiaPro-MS
Project Q3989004 in Netherlands

    Statements

    0 references
    77,765.63 Euro
    0 references
    444,375.0 Euro
    0 references
    17.5 percent
    0 references
    1 July 2015
    0 references
    30 June 2017
    0 references
    Drug Target ID
    0 references
    Orikami
    0 references
    0 references
    0 references

    51°50'50.32"N, 5°52'4.15"E
    0 references
    6525 EC
    0 references
    6511TM
    0 references
    MKB’s orikami en DTID werken samen om, op basis van het moleculaire MS landschap, een interactief en gemakkelijk toegankelijke applicatie (DiaPro MSapp) te ontwikkelen die individuele diagnostiek en prognose-bepaling voor MS-patiënten mogelijk maakt (Dutch)
    0 references
    SMEs orikami and DTID work together to develop, based on the molecular MS landscape, an interactive and easily accessible application (DiaPro MSapp) that enables individual diagnostics and prognosis for MS patients (English)
    15 December 2021
    0 references
    PME Orikami et dtid travaillent ensemble pour développer, sur la base du paysage moléculaire de la SEP, une application interactive et facilement accessible (DiaPro MSapp) qui permet un diagnostic et un pronostic individuels pour les patients atteints de SP (French)
    15 December 2021
    0 references
    KMU Orikami und dtid arbeiten zusammen, um basierend auf der molekularen MS-Landschaft eine interaktive und leicht zugängliche Anwendung (DiaPro MSapp) zu entwickeln, die eine individuelle Diagnostik und Prognose für MS-Patienten ermöglicht (German)
    15 December 2021
    0 references
    Le PMI Orikami e Dtid lavorano insieme per sviluppare, sulla base del panorama molecolare della SM, un'applicazione interattiva e facilmente accessibile (DiaPro MSapp) che consente la diagnosi individuale e la prognosi per i pazienti affetti da SM (Italian)
    11 January 2022
    0 references
    Las PYME Orikami y dtid colaboran para desarrollar, sobre la base del paisaje molecular de la EM, una aplicación interactiva y fácilmente accesible (DiaPro MSapp) que permita el diagnóstico individual y el pronóstico de los pacientes con EM (Spanish)
    12 January 2022
    0 references

    Identifiers

    OP-2014-2023-Oost-PROJ-00217
    0 references